Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial

• Autores principales: Willem D. F. Venter (Autor), Mohammed Majam (Autor), Godspower Akpomiemie (Autor), Natasha Arulappan (Autor), Michelle Moorhouse (Autor), Nonkululeko Mashabane (Autor), Matthew F. Chersich (Autor)
• Formato: Libro
• Publicado: BMC, 2017-07-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Abstract Background Screening for renal, hepatic and haematological disorders complicates the initiation of current first-line antiretroviral therapy (ART). Each additional test done adds substantial costs, both through direct laboratory expenses, but also by increasing the burden on health workers...